![](https://monteverdelaw.com/wp-content/uploads/case-logo/biotech-acquisition-company.jpg)
Biotech Acquisition Company (BIOT), relating to the proposed merger with Blade Therapeutics, Inc. Under the terms of the agreement, BIOT shareholders will retain only 36% of the combined company.
Biotech Acquisition Company (BIOT), relating to the proposed merger with Blade Therapeutics, Inc. Under the terms of the agreement, BIOT shareholders will retain only 36% of the combined company.